SCHEMBL4187918

SCHEMBL4187918

Nc1ccccc1NC(=O)c1ccc2c(c1)CCC2NC(=O)Nc1cccc(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.53
TRPV1 Q8NER1 6/20 0.48
HDAC3 O15379 4/20 0.46
HDAC2 Q92769 4/20 0.46
ALDH1A1 P00352 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
TAS1R2 Q8TE23 1/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
EPHX1 P07099 1/20 0.45
TSHR P16473 1/20 0.45
EPHX2 P34913 1/20 0.45
RAB9A P51151 1/20 0.45
NCOR2 Q9Y618 1/20 0.44
ACKR3 P25106 1/20 0.44
FADS1 O60427 1/20 0.43
HDAC4 P56524 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188146 0.91 LMNA (0.54) HDAC1TRPV1HDAC3HDAC2KMT2A
SCHEMBL4193646 0.91 ALDH1A1 (0.48) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL4190602 0.91 HDAC1 (0.54) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL4193715 0.90 KMT2A (0.48) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL4197796 0.89 HDAC3 (0.50) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL4189678 0.89 TRPV1 (0.49) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL4185425 0.89 KMT2A (0.58) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL13653257 0.87 TAS1R3 (0.56) HDAC1TRPV1HDAC3HDAC2TAS1R3
SCHEMBL4183093 0.86 HDAC3 (0.47) HDAC1TRPV1HDAC3HDAC2ALDH1A1
SCHEMBL13653256 0.86 HDAC1 (0.50) HDAC1TRPV1HDAC3HDAC2TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247590-A1 Indane amides MKI67, PPIP5K2, CCNA1 HDAC1 579/4885TRPV1 2361/4885HDAC3 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.